- Headquarters
- Burlingame, California
- Employees
- 11–50
- Founded
- 2011
- Business Model
- B2B
- Website
- cleavebio.com
- Total Funding
- $89.0M
- Last Round
- $37.0M Series BAug 2016
About
Cleave Biosciences (later renamed Cleave Therapeutics) is a biopharmaceutical company headquartered in Burlingame, California, focused on developing small molecule therapies targeting protein homeostasis and cellular stress pathways in cancer. The company's lead program centers on VCP/p97 inhibition as a novel mechanism for treating difficult-to-treat cancers.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Create Free AccountFunding History
Sign up to view funding details
Create a free account to see full funding history, valuations, and investor participation.
Create Free Account